161 related articles for article (PubMed ID: 26956213)
1. Analysis of clinical prognostic variables for Chronic Lymphocytic Leukemia decision-making problems.
deAndrés-Galiana EJ; Fernández-Martínez JL; Luaces O; Del Coz JJ; Huergo-Zapico L; Acebes-Huerta A; González S; González-Rodríguez AP
J Biomed Inform; 2016 Apr; 60():342-51. PubMed ID: 26956213
[TBL] [Abstract][Full Text] [Related]
2. Explainable machine learning for chronic lymphocytic leukemia treatment prediction using only inexpensive tests.
Meiseles A; Paley D; Ziv M; Hadid Y; Rokach L; Tadmor T
Comput Biol Med; 2022 Jun; 145():105490. PubMed ID: 35405402
[TBL] [Abstract][Full Text] [Related]
3. A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?
Strati P; Caligaris-Cappio F
Curr Opin Oncol; 2011 Sep; 23(5):455-60. PubMed ID: 21681094
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kyasa MJ; Parrish RS; Schichman SA; Zent CS
Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases.
Shvidel L; Tadmor T; Braester A; Bairey O; Rahimi-Levene N; Herishanu Y; Klepfish A; Shtalrid M; Berrebi A; Polliack A;
Ann Hematol; 2013 May; 92(5):661-7. PubMed ID: 23274356
[TBL] [Abstract][Full Text] [Related]
6. Unusual autoimmune nonhematologic complications in chronic lymphocytic leukemia.
Jung M; Rice L
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S10-3. PubMed ID: 22035737
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations.
De Back TR; Kater AP; Tonino SH
Expert Rev Hematol; 2018 Aug; 11(8):613-624. PubMed ID: 29923432
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunologic aspects of B chronic lymphocytic leukemia associated with autoimmune disorders.
Duek A; Shvidel L; Braester A; Berrebi A
Isr Med Assoc J; 2006 Dec; 8(12):828-31. PubMed ID: 17214095
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in chronic lymphocytic leukemia-what do we need to know?
Cramer P; Hallek M
Nat Rev Clin Oncol; 2011 Jan; 8(1):38-47. PubMed ID: 20956983
[TBL] [Abstract][Full Text] [Related]
10. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes.
Parikh SA; Leis JF; Chaffee KG; Call TG; Hanson CA; Ding W; Chanan-Khan AA; Bowen D; Conte M; Schwager S; Slager SL; Van Dyke DL; Jelinek DF; Kay NE; Shanafelt TD
Cancer; 2015 Sep; 121(17):2883-91. PubMed ID: 25931291
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune complications in chronic lymphocytic leukaemia (CLL).
Zent CS; Kay NE
Best Pract Res Clin Haematol; 2010 Mar; 23(1):47-59. PubMed ID: 20620970
[TBL] [Abstract][Full Text] [Related]
12. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience.
Laurenti L; Tarnani M; Nichele I; Ciolli S; Cortelezzi A; Forconi F; Rossi D; Mauro FR; D'Arena G; Del Poeta G; Montanaro M; Morabito F; Musolino C; Callea V; Falchi L; Tedeschi A; Ambrosetti A; Gaidano G; Leone G; Foà R
Am J Hematol; 2011 Dec; 86(12):1007-12. PubMed ID: 21953617
[TBL] [Abstract][Full Text] [Related]
13. Should a positive direct antiglobulin test be considered a prognostic predictor in chronic lymphocytic leukemia?
Ricci F; Tedeschi A; Vismara E; Colombo C; Veronese S; Nichelatti M; Cairoli R; Morra E; Montillo M
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):441-6. PubMed ID: 23773451
[TBL] [Abstract][Full Text] [Related]
14. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of clinical and laboratory parameters in patients with chronic lymphocytic leukemia.
Nenova I; Mateva N; Ananoshtev N; Grudeva-Popova J
Hematology; 2005 Feb; 10(1):47-51. PubMed ID: 16019445
[TBL] [Abstract][Full Text] [Related]
16. Improved Interpretability of Machine Learning Model Using Unsupervised Clustering: Predicting Time to First Treatment in Chronic Lymphocytic Leukemia.
Chen D; Goyal G; Go RS; Parikh SA; Ngufor CG
JCO Clin Cancer Inform; 2019 May; 3():1-11. PubMed ID: 31112417
[TBL] [Abstract][Full Text] [Related]
17. Prognosis Assessment of Early-Stage Chronic Lymphocytic Leukemia: Are We Ready to Predict Clinical Evolution Without a Crystal Ball?
González-Gascón-Y-Marín I; Muñoz-Novas C; Figueroa I; Hernández-Sánchez M; Rodríguez-Vicente AE; Quijada-Álamo M; Pérez-Carretero C; Moreno C; Collado R; Espinet B; Puiggros A; Heras NL; Bosch F; Hernández JÁ;
Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):548-555.e4. PubMed ID: 32389671
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia.
Byrd JC; Stilgenbauer S; Flinn IW
Hematology Am Soc Hematol Educ Program; 2004; ():163-83. PubMed ID: 15561682
[TBL] [Abstract][Full Text] [Related]
19. Secondary autoimmune cytopenias in chronic lymphocytic leukemia.
Rogers KA; Woyach JA
Semin Oncol; 2016 Apr; 43(2):300-10. PubMed ID: 27040709
[TBL] [Abstract][Full Text] [Related]
20. ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients.
Zanotti R; Frattini F; Ghia P; Visco C; Zamò A; Perbellini O; Stella S; Facco M; Giaretta I; Chilosi M; Pizzolo G; Ambrosetti A
Am J Hematol; 2010 Jul; 85(7):494-8. PubMed ID: 20575031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
